CN109527351A - A kind of health-care flour and preparation method thereof, wheaten food - Google Patents
A kind of health-care flour and preparation method thereof, wheaten food Download PDFInfo
- Publication number
- CN109527351A CN109527351A CN201811363681.2A CN201811363681A CN109527351A CN 109527351 A CN109527351 A CN 109527351A CN 201811363681 A CN201811363681 A CN 201811363681A CN 109527351 A CN109527351 A CN 109527351A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix paeoniae
- paeoniae alba
- health
- flour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013312 flour Nutrition 0.000 title claims abstract description 97
- 235000013305 food Nutrition 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 106
- 210000004369 blood Anatomy 0.000 claims abstract description 58
- 239000008280 blood Substances 0.000 claims abstract description 58
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 42
- 239000000203 mixture Substances 0.000 claims abstract description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 28
- 239000008103 glucose Substances 0.000 claims abstract description 28
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 27
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 27
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 25
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 25
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 25
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 22
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 13
- 238000004140 cleaning Methods 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims description 101
- 238000000605 extraction Methods 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- 239000000843 powder Substances 0.000 claims description 46
- 235000019441 ethanol Nutrition 0.000 claims description 44
- 230000000694 effects Effects 0.000 claims description 38
- 239000007787 solid Substances 0.000 claims description 34
- 235000009508 confectionery Nutrition 0.000 claims description 32
- 230000004044 response Effects 0.000 claims description 31
- 150000004676 glycans Chemical class 0.000 claims description 28
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 26
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 24
- 238000004458 analytical method Methods 0.000 claims description 23
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 22
- 230000008569 process Effects 0.000 claims description 22
- 235000000346 sugar Nutrition 0.000 claims description 22
- 238000002137 ultrasound extraction Methods 0.000 claims description 22
- 238000002474 experimental method Methods 0.000 claims description 21
- 229920001282 polysaccharide Polymers 0.000 claims description 21
- 239000005017 polysaccharide Substances 0.000 claims description 21
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 20
- 150000002772 monosaccharides Chemical class 0.000 claims description 20
- 241000026010 Dendrobium candidum Species 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 15
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims description 14
- 239000005711 Benzoic acid Substances 0.000 claims description 13
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 claims description 13
- 235000010233 benzoic acid Nutrition 0.000 claims description 13
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 claims description 13
- 239000013558 reference substance Substances 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 241001076416 Dendrobium tosaense Species 0.000 claims description 12
- 102000004877 Insulin Human genes 0.000 claims description 12
- 108090001061 Insulin Proteins 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 229940125396 insulin Drugs 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000013461 design Methods 0.000 claims description 11
- 229940074391 gallic acid Drugs 0.000 claims description 11
- 235000004515 gallic acid Nutrition 0.000 claims description 11
- 238000012216 screening Methods 0.000 claims description 11
- 210000002966 serum Anatomy 0.000 claims description 11
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 238000010172 mouse model Methods 0.000 claims description 10
- 102000004506 Blood Proteins Human genes 0.000 claims description 9
- 108010017384 Blood Proteins Proteins 0.000 claims description 9
- 229920000296 Glucogallin Polymers 0.000 claims description 9
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 9
- 239000013641 positive control Substances 0.000 claims description 9
- 238000011049 filling Methods 0.000 claims description 8
- 230000014759 maintenance of location Effects 0.000 claims description 8
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 7
- GDVRUDXLQBVIKP-HQHREHCSSA-N 1-O-galloyl-beta-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-HQHREHCSSA-N 0.000 claims description 7
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims description 7
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 claims description 7
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 7
- 235000005487 catechin Nutrition 0.000 claims description 7
- 229950001002 cianidanol Drugs 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 238000011156 evaluation Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000002329 infrared spectrum Methods 0.000 claims description 7
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims description 7
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims description 7
- 150000004804 polysaccharides Polymers 0.000 claims description 7
- 238000011084 recovery Methods 0.000 claims description 7
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 claims description 6
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 claims description 6
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 235000012149 noodles Nutrition 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000002604 ultrasonography Methods 0.000 claims description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 235000008429 bread Nutrition 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000005571 anion exchange chromatography Methods 0.000 claims description 4
- 238000012512 characterization method Methods 0.000 claims description 4
- 238000011697 diabetes animal model Methods 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 claims description 3
- 230000003044 adaptive effect Effects 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 3
- 210000003462 vein Anatomy 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000005211 surface analysis Methods 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 241000219094 Vitaceae Species 0.000 claims 1
- 235000021021 grapes Nutrition 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 21
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 7
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 5
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 5
- 150000002632 lipids Chemical class 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 4
- 238000003756 stirring Methods 0.000 abstract description 2
- 244000068988 Glycine max Species 0.000 description 20
- 235000010469 Glycine max Nutrition 0.000 description 20
- 244000013123 dwarf bean Species 0.000 description 17
- 235000021278 navy bean Nutrition 0.000 description 17
- 244000000626 Daucus carota Species 0.000 description 16
- 235000002767 Daucus carota Nutrition 0.000 description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 16
- 241001092040 Crataegus Species 0.000 description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 14
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 14
- 241000245665 Taraxacum Species 0.000 description 12
- 241000209140 Triticum Species 0.000 description 12
- 235000021307 Triticum Nutrition 0.000 description 12
- 241001247821 Ziziphus Species 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 10
- 101150077894 dop1 gene Proteins 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 235000012054 meals Nutrition 0.000 description 9
- 238000005457 optimization Methods 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 235000001727 glucose Nutrition 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 229960003284 iron Drugs 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- -1 matter class Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 101100387915 Caenorhabditis elegans dop-4 gene Proteins 0.000 description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 229960004756 ethanol Drugs 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 101100387911 Caenorhabditis elegans dop-2 gene Proteins 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000013256 coordination polymer Substances 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 101150097115 dop-3 gene Proteins 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 208000006278 hypochromic anemia Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229930003658 monoterpene Natural products 0.000 description 4
- 235000002577 monoterpenes Nutrition 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 241001523681 Dendrobium Species 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 3
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 235000014786 phosphorus Nutrition 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- KSWRZJNADSIDKV-UHFFFAOYSA-N 8-amino-3-hydroxynaphthalene-1,6-disulfonic acid Chemical compound OC1=CC(S(O)(=O)=O)=C2C(N)=CC(S(O)(=O)=O)=CC2=C1 KSWRZJNADSIDKV-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010049077 Hernia pain Diseases 0.000 description 2
- 101000588476 Homo sapiens [heparan sulfate]-glucosamine N-sulfotransferase NDST3 Proteins 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 102100031395 [heparan sulfate]-glucosamine N-sulfotransferase NDST3 Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 201000004484 acute conjunctivitis Diseases 0.000 description 2
- 208000012873 acute gastroenteritis Diseases 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 239000011973 solid acid Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 description 1
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003214 pyranose derivatives Chemical group 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention belongs to food flour technical fields, a kind of health-care flour and preparation method thereof, wheaten food are disclosed, health-care flour is made of according to mass fraction 1 part -10 parts of pueraria lobata, 1 part~5 parts of Radix Paeoniae Alba, 1 part~5 parts of dendrobium nobile, 1 part~2 parts of purslane, 1 part~2 parts of lotus leaf and 10 parts~20 parts of flour;Preparation method: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, cleaning, drying, disinfection are spare;Chinese medicine material is crushed, is sieved for subsequent use;Weigh 1 part -10 parts of pueraria lobata, 1 part~5 parts of Radix Paeoniae Alba, 1 part~5 parts of dendrobium nobile, 1 part~2 parts of purslane, 1 part~2 parts of lotus leaf mixed with 10 parts~20 parts of flour, stir evenly, be made mixture;Mixture is subjected to separating twice, sterilizes, packs to obtain health-care flour.The present invention, which has, to be adjusted blood glucose, adjusts the healthcare functions such as blood lipid, prevention cardiovascular and cerebrovascular disease, and good mouthfeel.
Description
Technical field
The invention belongs to food flour technical fields more particularly to a kind of health-care flour and preparation method thereof, wheaten food.
Background technique
Flour is a kind of Major Foods of people's long-term consumption, and amount is huge." flour " often said refers to wheat flour, i.e., with small
Wheat grinds the powder come;Flour is a kind of powder worn by wheat, by the number of protein content in flour, can be divided into height
Gluten flour, Plain flour, Self- raising flour and without gluten flour;Flour (wheat flour) is the staple food of north of China most area, is used
Food variety made of flour is various, makes a lot of variety, and flavor is totally different.Existing flour is only capable of providing basic nutrition, meets full abdomen
It needs, has a single function, do not have health-care effect, can not achieve the function for adjusting blood glucose, adjusting blood lipid, preventing cardiovascular and cerebrovascular disease
Energy.Hyperglycemia, hyperlipidemia disease incidence are year after year at ascendant trend after improving for present people's living standard, due to cardiovascular and cerebrovascular disease
Lethality caused by disease reaches the whole world first;Thus effectively prevent blood glucose rise from the food of intake, blood lipid is increased and reduced
Therefore a series of complication of bring are significant.
Dendrobium candidum DendrobimnofficinaleKimuraet Migo is in the time-honored common preciousness of one kind
Medicine is distributed mainly on China Guangxi, peace for orchid family Dendrobium perennial grow nonparasitically upon another plant herbaceous plant also known as admirable in all its details grass, iron sheet orchid
The ground such as emblem, Zhejiang, Fujian, Sichuan and Yunnan are used as medicine with fresh or dry stem, there is reinforcing stomach reg fluid, nourishing Yin and clearing heat, moistening lung to stop
Cough, improving eyesight salubrity and other effects are yin-nourishing key medicines.
Modern study proves that dendrobium candidum contains polysaccharide, amino acid, alkaloid isoreactivity ingredient, have anti-oxidant, anti-swollen
Tumor, adjusts immunity, hypoglycemic and other effects at anti-aging, and the polyoses content highest in all active constituents, structure is complicated, is it
The research of the material base of diverse biological activities, Dendrobium officinale polysaccharide component and its level-one, secondary structure is of great significance.
It focuses mostly at present about the research of Dendrobium officinale polysaccharide in different parts Thick many candies content, Thick many candies antioxidant activity
Etc..Thick many candies isolate and purify after structure and biological activity research it is less.The present invention carries out dendrobium candidum Thick many candies
It isolates and purifies, research institute obtains the monosaccharide composition and structure feature of separating polyose, and investigates the hypoglycemic activity of different separating polyoses.
Radix Paeoniae Alba is the dry root of ranunculaceae plant Chinese herbaceous peony PaeonialactifloraPall., has nourishing blood for regulating menstruation, holds back yin
The benefits of hidroschesis, the analgesic of soft liver, suppressing liver-YANG, medicinal history is long.Its monoterpene being rich in and its glycoside, triterpenes, flavonoids, tan
The compounds such as matter class, organic acid, polysaccharide are its material bases for playing drug effect.The current extraction in relation to Radix Paeoniae Alba chemical component is ground
Study carefully and have been reported that more, but spininess respectively holds oneself to Paeoniflorin and total glucosides of paeony, and on the technological parameters such as extracting method, Extraction solvent
By reliable extracting method can not be provided for the thoroughly evaluating of Radix Paeoniae Alba quality.
In conclusion problem of the existing technology is:
Existing flour is only capable of providing basic nutrition, meets full abdomen needs, has a single function, do not have health-care effect, cannot
Realize the function of adjusting blood glucose, adjust blood lipid, prevent cardiovascular and cerebrovascular disease.
Traditional uniform design and orthogonal design method is extracted in effective component of paeonia lactiflora, test accuracy is low, test number (TN) is more,
Mathematical model prediction good job causes the application in health-care flour limited.
Summary of the invention
In view of the problems of the existing technology, the present invention provides a kind of health-care flours and preparation method thereof, wheaten food.
The invention is realized in this way a kind of health-care flour and preparation method thereof, wheaten food, the health-care flour according to
Mass fraction is by 1 part -10 parts of pueraria lobata, 1 part~5 parts of Radix Paeoniae Alba, 1 part~5 parts of dendrobium nobile, 1 part~2 parts of purslane, 1 part~2 parts of lotus leaf
It is formed with 10 parts~20 parts of flour.
Another object of the present invention is to provide a kind of health-care flour and preparation method thereof, wheaten food, the health-care noodles
The preparation method of powder, comprising the following steps:
Step 1: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, cleaning, drying, disinfection are spare;
Step 2: Chinese medicine material is crushed, and is sieved for subsequent use;
Step 3, weigh 1 part -10 parts of pueraria lobata in step 3,1 part~5 parts of Radix Paeoniae Alba, 1 part~5 parts of dendrobium nobile, 1 part of purslane~
2 parts, 1 part~2 parts of lotus leaf are mixed with 10 parts~20 parts of flour, are stirred evenly, and mixture is made;
Mixture is carried out separating twice by step 4, and sterilization, packaging obtains health-care flour.
Further, in step 2, granularity is less than the granularity equal to flour after the crushing of Chinese herb;
Another object of the present invention is to provide the wheaten food prepared by the health-care flour include health-care powder steamed bun,
Health care flour noodle, health-care powder food with filling, health-care powder bread, health-care powder cake;
Further, health-care powder steamed bun, health-care powder bread, health-care powder cake can according to for different from consumer's age,
It is fabricated to different shape and taste;
Further, health care flour noodle, from consumer's age, can be fabricated to different taste according to for difference;
Further, health-care powder food with filling includes dumpling, won ton, pie, steamed stuffed bun, roulade etc..
Another object of the present invention is to provide a kind of extracting method of Radix Paeoniae Alba in health-care flour, the Radix Paeoniae Alba is mentioned
Taking method includes: to choose suitable parameter level by experiment of single factor, and use the Responds Surface Methodology of Three factors-levels
The extraction time of Radix Paeoniae Alba ultrasonic extraction process, concentration of alcohol, liquid-to-solid ratio are analyzed, it is super for obtaining optimal extract process
Sound time 20.06min, concentration of alcohol 72.04%, liquid-to-solid ratio 53.38mLg- 1。
Further, the extracting method of the Radix Paeoniae Alba specifically includes: taking radix paeoniae alba decoction pieces to crush, crosses 50 meshes, precision weighs suitable
Amount, sets in boiling flask, and the appropriate amount of ethanol of respective concentration, weighed, 40kHz is added, and 150W ultrasonic extraction is taken out and stood to room
Temperature, weighed quality of supplying is to get Radix Paeoniae Alba.
Further, in Radix Paeoniae Alba ultrasonic extraction,
On the basis of single factor experiment, the level value of 3 liquid-to-solid ratio, concentration of alcohol and ultrasonic time factors is determined, use
Design-Expert8.0.6 software carries out the design of Box-Behnken response surface and data carry out variance analysis and quadratic polynomial
Regression fit, regression model P are 0.0032, and model is extremely significant;Losing quasi- item P is 0.2360, not significantly;The coefficient of determination is
0.9677, the models fitting degree is good;Factor A, B, B2, C2To significantly affect factor, illustrate on Radix Paeoniae Alba extraction effect influence compared with
Greatly;Model is optimized manually, on the basis of original fit equation, removes not significant item BC and A2Afterwards, optimize resulting reality
Actual value equation:
R=2.2806 × 107+7.8125×104A+4.7447×108B+1.5284×108C-1.3857 × 103AB-
1.6157×103AC-3.1633 × 104B2- 3.0159 × 104C2。
Further, the extraction time with the Responds Surface Methodology of Three factors-levels to Radix Paeoniae Alba ultrasonic extraction process, second
Before determining alcohol, liquid-to-solid ratio are analyzed, need to carry out:
Reference substance solution preparation weighs gallic acid, catechin, albiflorin, Paeoniflorin, benzoic acid, 1,2,3,4,6-
Five galloyl glucose of O-, benzoylpaeoniflorin and Paeonol reference substance are appropriate, add methanol every 1mL is made to contain respectively and do not eat
Sub- acid 15.07 μ g, 5.49 μ g of catechin, 11.79 μ g of albiflorin, 35.15 μ g of Paeoniflorin, benzoic acid 7.87 μ g, 1,2,3,
The mixing reference substance of 4,6-O- five galloyl glucose, 7.84 μ g, 3.92 μ g of benzoylpaeoniflorin, 7.94 μ g of Paeonol are molten
Liquid shakes up, 4 DEG C of storages, spare.
The UPLC analysis condition of Radix Paeoniae Alba
ACQUITYUPLC HSST3 chromatographic column 2.1mm × 100mm, 1.8 μm;- 0.05% phosphoric acid water of mobile phase acetonitrile (A)
Solution (B), gradient: 0~0.5min, 7%~14%A;0.5~3min, 14%A;3~5.5min, 14%~18%A;
5.5~6min, 18%~20%A;6~9min, 20%~22%A;9~9.5min, 22%~40%A;9.5~11min,
40%~50%A;11~11.5min, 50%~100%A;11.5~12min,
100%A;12~12.5min, 100%~7%A;12.5~14min, 7%A.Detection wavelength 230nm;Column temperature 30
℃;Flow velocity 0.4mLmin- 1;2 μ L of sample volume.
The preliminary screening of Radix Paeoniae Alba ultrasonic method extracting method:
10 parts of radix paeoniae alba decoction pieces powder 0.5g is weighed, is placed in boiling flask, 50% ethyl alcohol 50mL of each addition, weighed quality,
Wherein 5 parts of samples difference heating and refluxing extractions 0.5,1,1.5,2,2.5h, another 5 parts of samples difference ultrasonic extraction 10,30,50,70,
90min;Standing is extracted to room temperature, weighed to supply quality, 0.22 μm of filtering with microporous membrane takes subsequent filtrate;It selects in chromatogram
11 shared peaks of S/N > 20 are as evaluation index, and the unit crude drug peak area handled with ultrasonic 30min calculates for 100%
The shared peak peak area recovery rate of different disposal sample, is compared;Different Extraction Method is to 2,7, No. 8 peak peak area recovery rates
Be affected, on remaining share peak peak area influence it is not significant;It is tentatively pushed away by retention time corresponding with reference substance map
Survey: No. 2 peaks are gallic acid peak, and No. 7 peaks are benzoic acid peak, and No. 8 peaks are 1,2,3,4,6-O- five galloyl glucoses
Peak.
Another object of the present invention is to provide a kind of method for verifying dendrobium nobile effect of lowering blood sugar in the health-care flour, institutes
Stating the method for verifying dendrobium nobile effect of lowering blood sugar includes:
Dendrobium candidum Thick many candies are separated using DEAE- cellulose anion exchange chromatography, Trimethylsilation method is surveyed
Determine the monosaccharide composition of separating polyose, the structure of infrared spectrum characterization separating polyose;Using model induced by alloxan diabetes mice mould
Influence of the type analysis separating polyose to model mice fasting blood sugar, serum insulin level and glycated serum protein content.
Further, the method for the verifying dendrobium nobile effect of lowering blood sugar specifically includes:
1) extraction of dendrobium nobile Thick many candies DOP;
2) dendrobium nobile Thick many candies (DOP) is isolated and purified;
3) monosaccharide composition analysis of dendrobium candidum separating polyose;
4) IR spectrum scanning of dendrobium candidum separating polyose component;
5) Dendrobium officinale polysaccharide hypoglycemic effect is analyzed: mouse modeling, grouping and administration take 18~22g of weight male
100 small, adaptive feeding 3d selects 10 at random and is only used as Normal group, remaining mouse fasting 12h, free water,
Alloxan normal saline solution is injected intraperitoneally under 200mg/kg dosage, establishes diabetes animal model;Fasting 12h, after 72h
Tail vein blood measurement fasting blood sugar, blood glucose value >=13mmol/L and continuously appearance " three-many-one-little " symptom, modeling success are small
Mouse;
Proportionately mould animal body quality and blood glucose level randomly choose 60 and are divided into 6 in successful 75 mouse of modeling
Group, respectively model group, positive controls, DOP140mg/kg group, DO P240mg/kg group, DOP340mg/kg group and DOP4
40mg/k g group;
It is administered by following scheme: control group and pure water 20mL/kg stomach-filling daily after model group modeling 7d;Positive controls are given
200mg/kg melbine is given, polysaccharide group presses the daily gastric infusion of various dose 1 time, continuous 21d, fasting 12h after administration.
In conclusion advantages of the present invention and good effect are as follows:
The health-care flour that the present invention obtains, which has, to be adjusted blood glucose, adjusts the healthcare functions such as blood lipid, prevention cardiovascular and cerebrovascular disease,
And good mouthfeel.
Carrot rich in carbohydrate, fat, volatile oil, carrotene, vitamin A, vitamin B1, vitamin B2, anthocyanidin,
The nutritional ingredient of the needed by human body such as calcium, iron;And carrot is sweet in flavor, pungent, tepor is nontoxic;Cure mainly lower gas bowl spares, sharp chest diaphragm stomach,
Five viscera settling makes us strong food, only does good, not harm.
The medical value of navy bean, kidney bean is very high;Ancient Times in China medicine writings are recorded, sweet taste, have warming the middle warmer and descending qi, sharp intestines
The functions such as stomach, kidney-nourishing complement are a kind of nourishing diet good foods;There are also sedations for kidney bean, vomit to treatment cold of insufficiency type hiccup, stomach cold
It spits, traumatic injury, cough of wheezing, pain in the loins, neuralgia have certain curative effect;Kidney bean or a kind of hyperkalemia hyponatremia food, are well suited for
In heart disease, artery sclerosis, hyperlipidemia and avoid salt edible for patients;Modern medical analysis, kidney bean grain are more containing hemagglutinin etc.
Kind globulin.
Pea, sweet and neutral are nontoxic;Pea nutritive value: it is rich in vitamin C in the tender leaf of pea pods and bean seedlings and can divide
The enzyme of internal nitrosamine is solved, there can be anti-cancer and cancer-preventing with decomposing nitrosamine;Contained by pea stop wooden fork acid, gibberellin and
Plant coagulates the substances such as element, has antibacterial anti-inflammatory, enhances the function of metabolism.
Green soya bean is rich in unsaturated fatty acid and soybean lecithin, has and keeps blood vessel elasticity, brain tonic and prevent fatty liver from being formed
Effect;Rich in the anticancer components such as saponin, protease inhibitors, isoflavones, molybdenum, selenium in green soya bean, to prostate cancer, cutaneum carcinoma,
The almost all of cancer such as intestinal cancer, cancer of the esophagus has inhibiting effect;Green soya bean is also rich in vitamin in addition to containing protein and fiber
A, vitamin C and vitamin K and vitamin B;Green soya bean can provide calcium, phosphorus, potassium, iron, zinc, thiamine and riboflavin.
Kudzu-vine root powder provided by the invention: inducing diaphoresis is brought down a fever, and is promoted the production of body fluid, promoting eruption, Shengyang Zhixie.
Radix Paeoniae Alba: returning liver, spleen, lung three to pass through, calming the liver and relieving pain, nourishing blood for regulating menstruation, astringing YIN to stop sweating;For headache and dizziness, hypochondriac pain, abdomen
Bitterly, four limbs contraction pain, blood deficiency chlorosis, irregular menstruation, spontaneous perspiration, night sweat.
Dendrobium nobile: nature and flavor are sweet, slightly cold;Channel tropism returns stomach, kidney channel;Major function reinforcing stomach reg fluid, nourishing Yin and clearing heat.For impairment of yin saliva
Thanks to, dry polydipsia, deficiency of food are retched, and abnormal heat, mesh are secretly unknown after being ill.
Purslane: purslane two oxyethylamines, malic acid, glucose, calcium, phosphorus, iron and vitamin E rich in, Hu
The nutriments such as radish element, vitamin B, vitamin C.Purslane nutritionally has the characteristics that prominent, its 3 fat of ω-
Acid content is higher than people and plant.3 fatty acid of ω-can inhibit human body to reduce serum cholesterol concentration, change the absorption of the solid acid of gallbladder
Kind vessel wall elasticity, it is highly advantageous to prevention and cure of cardiovascular disease;Nature and flavor acid, trembles with fear;Major function clearing heat and promoting diuresis, removing pattogenic heat from the blood and toxic material from the body;For
Bacillary dysentery, acute gastroenteritis, acute appendicitis, mazoitis, hemorrhoid hemorrhage, leukorrhea;Furuncle swelling toxin, eczema, band are controlled in external application
Shape bleb.
Lotus leaf: Nelumbonaceae Nelumbo perennial herb emergent aquactic plant;Mainly there are clearing away summerheat, sending up the lucid yang, the function of dissipating stasis and stanching bleeding
Effect;Clearing away summer-heat and eliminating dampness, sending up the lucid yang, cooling blood and hemostasis;Effectiveization rouge alkaloid there are many containing in Nuciferine in lotus leaf tea, can have
Effect decomposes intracorporal fat, and powerful excretes.
Dandelion: it is specific clearing heat and detoxicating, the effect of diuresis dissipating bind.Cure mainly acute mastitis, adenolymphitis, scrofula, serious case of furuncle
Sore swells, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urinary tract infections.
Fructus lycii: nature and flavor sweet and neutral;Return liver and kidney channel;Major function is nourishing liver and kidney, benefiting shrewd head;For consumption consumptive loss, waist and knee
Ache, dizziness and tinnitus, Heat Diabetes, blood deficiency chlorosis, blurred vision.
Jujube: nature and flavor sweet, warm;Returns spleen, stomach meridian;Major function tonifying middle-Jiao and Qi, nourishing blood and tranquilization;It is out of strength for spleen eating less
Loose stool, hysteria of womam.
Dried orange peel: damp retention in middle-jiao, stomach duct and abdomen swollen ruffian, loose stool diarrhea, diet reduction, indigestion, stool diarrhea are used for.
Hawthorn: nature and flavor are sour, sweet, tepor;Returns spleen, stomach, Liver Channel;Major function food digesting stomach fortifying, scattered stasis.For meat product
It is stagnant, gastral cavilty turgor, diarrhea dysentery abdominal pain, blood stasis closed, postpartum stasis, confidant sting, hernia pain;Hyperlipidemia.Charred FRUCTUS CRATAEGI helps digestion
Promoting effect enhancing.For meat stagnation, dysentery is not well.
The present invention separates dendrobium candidum Thick many candies using DEAE- cellulose anion exchange chromatography, and trimethylsilyl ethers is derivative
Change method measures the monosaccharide composition of separating polyose, the structure of infrared spectrum characterization separating polyose.Using model induced by alloxan mouse sugar
Disease model research separating polyose is urinated to the shadow of model mice fasting blood sugar, serum insulin level and glycated serum protein content
It rings.
Isolated 4 kinds of separating polyoses in dendrobium nobile, the monosaccharide group of content highest separating polyose DOP1 become arabinose, half
Lactose, glucose and mannose (molar ratio 3.5: 1.2: 1.5: 1.0).Results of IR and monosaccharide composition research phase
Symbol, while showing that 4 kinds of separating polyoses are sulfated polysaccharide.4 kinds of separating polyoses can significantly reduce diabetes after 21d is administered
The fasting blood sugar (P < 0.01) of model mice improves serum insulin level (P < 0.05~0.01) and reduces saccharification
Serum albumin content (P < 0.01), wherein being acted on DOP1 most strong.
Dendrobium nobile separating polyose has significant hypoglycemic effect.
To advanced optimize Radix Paeoniae Alba extraction process, chemically ingredient stability and operation convenience consider, the experimental selection
Ultrasonic method analyzes Radix Paeoniae Alba extraction process.Using the total peak area for sharing peak in liquid chromatogram as index, pass through single factor test
Method investigates the influence of ultrasonic time, concentration of alcohol, liquid-to-solid ratio to Radix Paeoniae Alba extraction effect, and with the super of response phase method optimization Radix Paeoniae Alba
Sound extraction process.
The experimental results showed that influence maximum of the concentration of alcohol to Radix Paeoniae Alba extraction effect, followed by liquid-to-solid ratio and ultrasonic time.
Response phase method optimize Radix Paeoniae Alba ultrasonic extraction process optimum condition are as follows: ultrasonic time 20.06min, concentration of alcohol 72.04%,
Liquid-to-solid ratio 53.38mLg- 1;The model predication value that peak total peak area is shared in chromatogram is 2.1608 × 108.It is real by verifying
Issue after examination and approval existing: under this optimum extraction condition, the actual value that peak total peak area is shared in chromatogram is 2.1422 × 108, with prediction
It is worth close, the two relative deviation is 0.86%, illustrates that the resulting Radix Paeoniae Alba extraction process of response surface optimization is stable, feasible.From Radix Paeoniae Alba
Extraction effect completely, sufficiently from the point of view of, which obtains Paeoniflorin extraction side in technique " Radix Paeoniae Alba " contained compared with " Chinese Pharmacopoeia "
Method has more advantage, can be used for the exploitation, utilization and quality overall evaluation of health-care flour Radix Paeoniae Alba.
Response surface design is a kind of effectively statistics and optimization method, with traditional uniform design compared with orthogonal design,
Response phase method has many advantages, such as that test accuracy is high, test number (TN) is few, mathematical model prediction is good,
And it can reflect the relationship between each factor and response.Therefore the present invention is to ring to share peak total peak area in chromatogram
It should be worth, carry out the experimental design of Box-Behnken response surface with Design-Expert software, Radix Paeoniae Alba extraction process be carried out excellent
Change, provides reliable method for overall merit Radix Paeoniae Alba quality.
The present invention first passes through experiment of single factor and chooses suitable parameter level, and with the response surface of Three factors-levels point
Analysis method investigates the extraction time of Radix Paeoniae Alba ultrasonic extraction process, concentration of alcohol, liquid-to-solid ratio, obtains optimal extract process
For ultrasonic time 20.06min, concentration of alcohol 72.04%, liquid-to-solid ratio 53.38mLg- 1, and work is demonstrated by confirmatory experiment
The feasibility of skill, and at the process conditions, the extraction effect of Radix Paeoniae Alba chemical component more fully, sufficiently, can be used for Radix Paeoniae Alba matter
The overall merit of amount, and foundation is provided for the comprehensive utilization of Radix Paeoniae Alba, exploitation.
Detailed description of the invention
Fig. 1 is the preparation method flow chart of health-care flour provided in an embodiment of the present invention.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to
Limit the present invention.
Application principle of the invention is explained in detail with reference to the accompanying drawing.
Health-care flour provided in an embodiment of the present invention, the health-care flour is according to mass fraction by 8-10 parts of pueraria lobata, Radix Paeoniae Alba 3
~5 parts, 3~5 parts of dendrobium nobile, 2~6 parts of purslane, 1~2 part of lotus leaf, 2~4 parts of dandelion, 1~3 part of fructus lycii, 1~2 part of jujube,
3~5 parts of dried orange peel, 3~5 parts of hawthorn, 10~16 parts of carrot meal, 8~12 parts of navy bean, 30~50 parts of peameal, green soya bean flour 10
~20 parts and 200~250 parts of wheat flour compositions.
The present invention will be described in further detail with reference to the accompanying drawing;
As shown in Figure 1, the preparation method of health-care flour provided in an embodiment of the present invention, comprising the following steps:
S101: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, dandelion, fructus lycii, jujube, dried orange peel,
Hawthorn, cleaning, drying, disinfection are spare;
S102: Chinese medicine material is successively pulverized and sieved using micronizer, obtains Chinese medicine fine powder, spare;
S103: carrot being selected, is cleaned, dries pulverizing acquisition carrot meal, spare;It is successively right using screening machine
Navy bean, pea and green soya bean carry out screening and removing impurities, and cleaning, drying crushes, and obtain navy bean powder, peameal and green soya bean flour, spare;
S104: pueraria lobata 8-10 parts, 3~5 parts of Radix Paeoniae Alba, 3~5 parts of dendrobium nobile, purslane 2~6 are successively added into wheat flour
Part, 1~2 part of lotus leaf, 2~4 parts of dandelion, 1~3 part of fructus lycii, 1~2 part of jujube, 3~5 parts of dried orange peel, 3~5 parts of hawthorn, Hu Luo
Foretell 10~16 parts of powder, 8~12 parts of navy bean, 30~50 parts of peameal, 10~20 parts of green soya bean flour mixed, stir evenly, make
Obtain mixture;
S105: mixture is subjected to separating twice, filtering, sterilization pack 15~20kg/ bags, obtain health-care flour.
In step S102, granularity is less than or equal to of flour after the crushing of Chinese herb provided in an embodiment of the present invention
Granularity.
The wheaten food of health-care flour provided in an embodiment of the present invention preparation include health-care powder steamed bun, health care flour noodle,
Health-care powder food with filling, health-care powder bread, health-care powder cake;
Health-care powder steamed bun provided in an embodiment of the present invention, health-care powder bread, health-care powder cake can according to for it is different from
Consumer's age is fabricated to different shape and taste;
Health care flour noodle provided in an embodiment of the present invention, from consumer's age, can be fabricated to different mouths according to for difference
Taste;
Health-care powder food with filling provided in an embodiment of the present invention includes dumpling, won ton, pie, steamed stuffed bun, roulade etc..
Below with reference to pharmacology analysis, invention is further explained;
Radix Paeoniae Alba: returning liver, spleen, lung three to pass through, calming the liver and relieving pain, nourishing blood for regulating menstruation, astringing YIN to stop sweating;For headache and dizziness, hypochondriac pain, abdomen
Bitterly, four limbs contraction pain, blood deficiency chlorosis, irregular menstruation, spontaneous perspiration, night sweat;
Dendrobium nobile: nature and flavor are sweet, slightly cold;Channel tropism returns stomach, kidney channel;Major function reinforcing stomach reg fluid, nourishing Yin and clearing heat.For impairment of yin saliva
Thanks to, dry polydipsia, deficiency of food are retched, and abnormal heat, mesh are secretly unknown after being ill.
Purslane: purslane two oxyethylamines, malic acid, glucose, calcium, phosphorus, iron and vitamin E rich in, Hu
The nutriments such as radish element, vitamin B, vitamin C.Purslane nutritionally has the characteristics that prominent, its 3 fat of ω-
Acid content is higher than people and plant.3 fatty acid of ω-can inhibit human body to reduce serum cholesterol concentration, change the absorption of the solid acid of gallbladder
Kind vessel wall elasticity, it is highly advantageous to prevention and cure of cardiovascular disease;Nature and flavor acid, trembles with fear;Major function clearing heat and promoting diuresis, removing pattogenic heat from the blood and toxic material from the body;For
Bacillary dysentery, acute gastroenteritis, acute appendicitis, mazoitis, hemorrhoid hemorrhage, leukorrhea;Furuncle swelling toxin, eczema, band are controlled in external application
Shape bleb.
Lotus leaf: Nelumbonaceae Nelumbo perennial herb emergent aquactic plant;Mainly there are clearing away summerheat, sending up the lucid yang, the function of dissipating stasis and stanching bleeding
Effect;Clearing away summer-heat and eliminating dampness, sending up the lucid yang, cooling blood and hemostasis;Effectiveization rouge alkaloid there are many containing in Nuciferine in lotus leaf tea, can have
Effect decomposes intracorporal fat, and powerful excretes.
Dandelion: it is specific clearing heat and detoxicating, the effect of diuresis dissipating bind.Cure mainly acute mastitis, adenolymphitis, scrofula, serious case of furuncle
Sore swells, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urinary tract infections.
Fructus lycii: nature and flavor sweet and neutral;Return liver and kidney channel;Major function is nourishing liver and kidney, benefiting shrewd head;For consumption consumptive loss, waist and knee
Ache, dizziness and tinnitus, Heat Diabetes, blood deficiency chlorosis, blurred vision.
Jujube: nature and flavor sweet, warm;Returns spleen, stomach meridian;Major function tonifying middle-Jiao and Qi, nourishing blood and tranquilization;It is out of strength for spleen eating less
Loose stool, hysteria of womam.
Dried orange peel: damp retention in middle-jiao, stomach duct and abdomen swollen ruffian, loose stool diarrhea, diet reduction, indigestion, stool diarrhea are used for.
Hawthorn: nature and flavor are sour, sweet, tepor;Returns spleen, stomach, Liver Channel;Major function food digesting stomach fortifying, scattered stasis.For meat product
It is stagnant, gastral cavilty turgor, diarrhea dysentery abdominal pain, blood stasis closed, postpartum stasis, confidant sting, hernia pain;Hyperlipidemia.Charred FRUCTUS CRATAEGI helps digestion
Promoting effect enhancing.For meat stagnation, dysentery is not well.
Application principle of the invention is further described combined with specific embodiments below.
Embodiment 1:
(1) health-care flour provided in an embodiment of the present invention, the health-care flour is according to mass fraction by 8 parts of pueraria lobata, Radix Paeoniae Alba
3 parts, 3 parts of dendrobium nobile, 2 parts of purslane, 1 part of lotus leaf, 2 parts of dandelion, 1 part of fructus lycii, 1 part of jujube, 3 parts of dried orange peel, 3 parts of hawthorn, Hu Luo
Foretell 10 parts of powder, 8 parts of navy bean, 30 parts of peameal, 10 parts of green soya bean flour and 200 parts of wheat flour compositions.
(2) preparation method of health-care flour provided in an embodiment of the present invention, comprising the following steps:
S101: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, dandelion, fructus lycii, jujube, dried orange peel,
Hawthorn, cleaning, drying, disinfection are spare;
S102: Chinese medicine material is successively pulverized and sieved using micronizer, obtains Chinese medicine fine powder, spare;
S103: carrot being selected, is cleaned, dries pulverizing acquisition carrot meal, spare;It is successively right using screening machine
Navy bean, pea and green soya bean carry out screening and removing impurities, and cleaning, drying crushes, and obtain navy bean powder, peameal and green soya bean flour, spare;
S104: successively into wheat flour add 8 parts of pueraria lobata, 3 parts of Radix Paeoniae Alba, 3 parts of dendrobium nobile, 2 parts of purslane, 1 part of lotus leaf,
2 parts of dandelion, 1 part of fructus lycii, 1 part of jujube, 3 parts of dried orange peel, 3 parts of hawthorn, 10 parts of carrot meal, 8 parts of navy bean, 30 parts of peameal,
10 parts of green soya bean flour are mixed, and are stirred evenly, and mixture is made;
S105: mixture is subjected to separating twice, filtering, sterilization pack 15~20kg/ bags, obtain health-care flour.
Embodiment 2:
(1) health-care flour provided in an embodiment of the present invention, the health-care flour is according to mass fraction by 10 parts of pueraria lobata, white
5 parts of Chinese herbaceous peony, 5 parts of dendrobium nobile, 6 parts of purslane, 2 parts of lotus leaf, 4 parts of dandelion, 3 parts of fructus lycii, 2 parts of jujube, 5 parts of dried orange peel, 5 parts of hawthorn, Hu
16 parts of carrot powder, 12 parts of navy bean, 50 parts of peameal, 20 parts of green soya bean flour and 250 parts of wheat flour compositions.
(2) preparation method of health-care flour provided in an embodiment of the present invention, comprising the following steps:
S101: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, dandelion, fructus lycii, jujube, dried orange peel,
Hawthorn, cleaning, drying, disinfection are spare;
S102: Chinese medicine material is successively pulverized and sieved using micronizer, obtains Chinese medicine fine powder, spare;
S103: carrot being selected, is cleaned, dries pulverizing acquisition carrot meal, spare;It is successively right using screening machine
Navy bean, pea and green soya bean carry out screening and removing impurities, and cleaning, drying crushes, and obtain navy bean powder, peameal and green soya bean flour, spare;
S104: successively into wheat flour add 10 parts of pueraria lobata, 5 parts of Radix Paeoniae Alba, 5 parts of dendrobium nobile, 6 parts of purslane, 2 parts of lotus leaf,
4 parts of dandelion, 3 parts of fructus lycii, 2 parts of jujube, 5 parts of dried orange peel, 5 parts of hawthorn, 16 parts of carrot meal, 12 parts of navy bean, 50 parts of peameal,
20 parts of green soya bean flour are mixed, and are stirred evenly, and mixture is made;
S105: mixture is subjected to separating twice, filtering, sterilization pack 15~20kg/ bags, obtain health-care flour.
Embodiment 3:
(1) health-care flour provided in an embodiment of the present invention, the health-care flour is according to mass fraction by 9 parts of pueraria lobata, Radix Paeoniae Alba
4 parts, 4 parts of dendrobium nobile, 4 parts of purslane, 1.5 parts of lotus leaf, 3 parts of dandelion, 2 parts of fructus lycii, 1.5 parts of jujube, 4 parts of dried orange peel, 4 parts of hawthorn,
14 parts of carrot meal, 10 parts of navy bean, 40 parts of peameal, 15 parts of green soya bean flour and 225 parts of wheat flour compositions.
(2) preparation method of health-care flour provided in an embodiment of the present invention, comprising the following steps:
S101: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, dandelion, fructus lycii, jujube, dried orange peel,
Hawthorn, cleaning, drying, disinfection are spare;
S102: Chinese medicine material is successively pulverized and sieved using micronizer, obtains Chinese medicine fine powder, spare;
S103: carrot being selected, is cleaned, dries pulverizing acquisition carrot meal, spare;It is successively right using screening machine
Navy bean, pea and green soya bean carry out screening and removing impurities, and cleaning, drying crushes, and obtain navy bean powder, peameal and green soya bean flour, spare;
S104: 9 parts of pueraria lobata, 4 parts of Radix Paeoniae Alba, 4 parts of dendrobium nobile, 4 parts of purslane, lotus leaf 1.5 are successively added into wheat flour
Part, 3 parts of dandelion, 2 parts of fructus lycii, 1.5 parts of jujube, 4 parts of dried orange peel, 4 parts of hawthorn, 14 parts of carrot meal, 10 parts of navy bean, peameal
40 parts, 15 parts of green soya bean flour are mixed, and are stirred evenly, and mixture is made;
S105: mixture is subjected to separating twice, filtering, sterilization pack 15~20kg/ bags, obtain health-care flour.
Below with reference to Radix Paeoniae Alba extracting method in health-care flour of the invention, the invention will be further described.
To advanced optimize Radix Paeoniae Alba extraction process, chemically ingredient stability and operation convenience consider, the experimental selection
Ultrasonic method studies Radix Paeoniae Alba extraction process.Using the total peak area for sharing peak in liquid chromatogram as index, pass through single factor test
Method investigates the influence of ultrasonic time, concentration of alcohol, liquid-to-solid ratio to Radix Paeoniae Alba extraction effect, and with the super of response phase method optimization Radix Paeoniae Alba
Sound extraction process.
The experimental results showed that influence maximum of the concentration of alcohol to Radix Paeoniae Alba extraction effect, followed by liquid-to-solid ratio and ultrasonic time.
Response phase method optimize Radix Paeoniae Alba ultrasonic extraction process optimum condition are as follows: ultrasonic time 20.06min, concentration of alcohol 72.04%,
Liquid-to-solid ratio 53.38mLg- 1;The model predication value that peak total peak area is shared in chromatogram is 2.1608 × 108.It is real by verifying
Issue after examination and approval existing: under this optimum extraction condition, the actual value that peak total peak area is shared in chromatogram is 2.1422 × 108, with prediction
It is worth close, the two relative deviation is 0.86%, illustrates that the resulting Radix Paeoniae Alba extraction process of response surface optimization is stable, feasible.From Radix Paeoniae Alba
Extraction effect completely, sufficiently from the point of view of, which obtains Paeoniflorin extraction side in technique " Radix Paeoniae Alba " contained compared with " Chinese Pharmacopoeia "
Method has more advantage, can be used for the exploitation, utilization and quality overall evaluation of Radix Paeoniae Alba.
Specifically have:
1 material
Radix paeoniae alba decoction pieces are purchased from market, and acetonitrile, methanol are chromatographically pure (German Merck company);Phosphoric acid is that analysis is pure (commercially available);
95% ethyl alcohol is medicinal alcohol (commercially available).Gallic acid (purity 89.9%, lot number 110831-201204), catechin (purity
97.2%, lot number 110877-201203), benzoic acid (purity 100%, lot number
100419-201312), Paeoniflorin (purity 94.9%, lot number 110736-201337), Paeonol (purity 100%,
Lot number 110708-200506) reference substance be purchased from market;Albiflorin (purity 98%, lot number 20130625), benzoyl Chinese herbaceous peony
Glycosides (purity 98%, lot number 20140419) and 1,2,3,4,6-O- five galloyl glucose (purity 98%, lot numbers
20140511) reference substance is purchased from market.ACQUITYUPLCTMLiquid chromatograph, including binary solvent management system, sample introduction management
System, column management system, Generation of tunable UV detector and Empower3.0 chromatographic work station (Wa-ters company, the U.S.);
KQ3200E type ultrasonic cleaner (market);XS204 type analysis balance (Met-tlerToledo company, the U.S.);JJ1000 type
Electronic balance (market).
2 methods and result
2.1 reference substance solutions preparation precision weighs gallic acid, catechin, albiflorin, Paeoniflorin, benzoic acid, 1,
2,3,4,6-O- five galloyl glucoses, benzoylpaeoniflorin and Paeonol reference substance are appropriate, add methanol that every 1mL is made
The 15.07 μ g containing gallic acid respectively, 5.49 μ g of catechin, 11.79 μ g of albiflorin, 35.15 μ g of Paeoniflorin, benzoic acid 7.87
μ g, 1,2,3,4,6-O- five galloyl glucose, 7.84 μ g, 3.92 μ g of benzoylpaeoniflorin, the mixing of 7.94 μ g of Paeonol
Reference substance solution shakes up, 4 DEG C of storages, spare.
The UPLC analysis condition of 2.2 Radix Paeoniae Albas
ACQUITYUPLC HSST3 chromatographic column (2.1mm × 100mm, 1.8 μm);- 0.05% phosphoric acid of mobile phase acetonitrile (A)
Aqueous solution (B), gradient: 0~0.5min, 7%~14%A;0.5~3min, 14%A;3~5.5min, 14%~18%
A;5.5~6min, 18%~20%A;6~9min, 20%~22%A;9~9.5min, 22%~40%A;9.5~
11min, 40%~50%A;11~11.5min, 50%~100%A;11.5~12min,
100%A;12~12.5min, 100%~7%A;12.5~14min, 7%A.Detection wavelength 230nm;Column temperature 30
℃;Flow velocity 0.4mLmin- 1;2 μ L of sample volume.
2.3, the preliminary screening of Radix Paeoniae Alba extracting method:
Precision weighs 10 parts of 0.5g of radix paeoniae alba decoction pieces powder (crossing 50 meshes), is placed in boiling flask, each that 50% ethyl alcohol is added
50mL, weighed quality, wherein 5 parts of samples distinguish heating and refluxing extraction 0.5,1,1.5,2,2.5h, ultrasound mentions another 5 parts of samples respectively
Take 10,30,50,70,90min.Standing is extracted to room temperature, weighed to supply quality, 0.22 μm of filtering with microporous membrane takes continuous filter
Liquid, sample detection.The list for selecting 11 shared peaks of S/N > 20 in chromatogram as evaluation index, and being handled with ultrasonic 30min
Position crude drug peak area is 100%, calculates the shared peak peak area recovery rate of different disposal sample, is compared.Different extraction sides
Method is affected to 2,7, No. 8 peak peak area recovery rates, influences on remaining peak area for sharing peak not significant.By with compare
Product map corresponds to retention time can initial guess: No. 2 peaks are gallic acid peak, and No. 7 peaks are benzoic acid peak, and No. 8 peaks are 1,2,3,
4,6-O- five galloyl glucose peaks.Since heating reflux method Extracting temperature is higher than ultrasonic method, cause contained in Radix Paeoniae Alba
Nutgall acyl tannin more facile hydrolysis generates gallic acid or galloyl glucose;The benzoic acid ester bond of monoterpene glycosides substance is more
Easy fracture and generate benzoic acid.Therefore, gallic acid, benzoic acid and 1 in heating reflux method, 2,3,4,6-O- five galloyls
The peak area recovery rate of glucose is higher than ultrasonic method.It is super to comprehensively consider factors, the selections such as chemical composition stability, operation convenience
Sound method is the extracting method of Radix Paeoniae Alba.
The process flow of 2.4 Radix Paeoniae Alba ultrasonic extractions
It takes radix paeoniae alba decoction pieces to crush, crosses 50 meshes, precision is weighed in right amount, set in boiling flask, and the ethyl alcohol of respective concentration is added
In right amount, weighed, ultrasonic extraction (40kHz, 150W) is taken out and is stood to room temperature, it is weighed supply quality to get.
The single factor experiment of 2.5 Radix Paeoniae Alba ultrasonic extraction process parameters
Using 11 of S/N > 20 in chromatogram shared peak total peak areas as evaluation index, different ultrasounds is investigated respectively and is mentioned
Take the time (10,20,30,40,50min), concentration of alcohol (20%, 35%, 50%, 65%, 80%) and liquid-to-solid ratio (50: 1,
100: 1,250: 1,500: 1,800: 1mLg- 1) influence to Radix Paeoniae Alba extraction efficiency.
2.5.1 the fixed liquid-to-solid ratio of influence of the ultrasonic extraction time to extraction effect is 100: 1 (mLg- 1), concentration of alcohol
It is 50%, selection ultrasound 10,20,30,40,50min is tested.With the extension of ultrasonic time, share peak total peak area by
It is cumulative big;But after ultrasound 20min, shared peak total peak area tends to be steady, and extraction tends to be complete.To prevent ultrasonic time too long,
Extracting temperature is caused to increase, effective component is degraded in Radix Paeoniae Alba, therefore selects 20min for optimal ultrasonic time.
2.5.2 the fixed liquid-to-solid ratio of influence of the concentration of alcohol to extraction effect is 100: 1 (mLg- 1), ultrasonic time is
20min selects 20%, 35%, 50%, 65%, and 80% concentration of alcohol extracts test to Radix Paeoniae Alba, when concentration of alcohol is 65%
When, the total peak area at shared peak reaches peak value;When concentration of alcohol is 80%, extraction effect is weakened again, therefore selects 65%
For optimal concentration of alcohol.
2.5.3 the fixed ultrasonic time of influence of the liquid-to-solid ratio to extraction effect is 20min, and concentration of alcohol 50% selects liquid
Expect ratio 50: 1,100: 1,250: 1,500: 1,800: 1 (mLg- 1) tested, with the increase of liquid-to-solid ratio, share the total of peak
Peak area gradually increases, because Extraction solvent volume constantly increases, the contact surface of medicinal powder and solvent molecule also constantly increases,
Extracted amount is caused to be increasing;When liquid-to-solid ratio is greater than 100: 1 (mLg- 1), the growth trend of shared peak total peak area slows down, and extracts
Tend to be complete;But in view of being significantly increased for liquid-to-solid ratio may generate certain influence to extracting solution pH, make in Radix Paeoniae Alba to pH value
The content of material such as sensitive monoterpene glycosides, aromatic acid change, therefore select 100: 1 (mLg- 1) it is more excellent liquid-to-solid ratio.
2.6 response phase methods optimize the test of Radix Paeoniae Alba ultrasonic extraction process:
On the basis of single factor experiment, the level value of 3 liquid-to-solid ratio, concentration of alcohol and ultrasonic time factors is determined, use
Design-Expert8.0.6 software carries out the design of Box-Behnken response surface and data analysis.Specific experiment factor and each water
Level values see the table below.
Response surface experiments factor and level
According to the Combination Design principle of Box-Behnken, using 3 factor 3 of De-sign-Expert8.0.6 software design
Level is tested for 15 totally, wherein central point 3 repeated experiments;The total peak area at peak is shared with S/N > 20 in chromatogram as response
It is worth (R), specific experiment design scheme and result following table.
Response surface experimental result
The experimental design and results of response sur- face analysis
Variance analysis and quadratic polynomial regression fit are carried out to experimental data using Design-Expert8.0.6 software,
Regression model P is 0.0032, illustrates that model is extremely significant;Losing quasi- item P is 0.2360, not significantly;The coefficient of determination is 0.9677, explanation
The models fitting degree is good;Factor A, B, B2, C2To significantly affect factor, illustrate to be affected to Radix Paeoniae Alba extraction effect.For letter
Change equation, model is optimized manually, on the basis of original fit equation, removes not significant item BC and A2Afterwards, variance analysis
As a result it see the table below, optimize resulting actual value equation:
R=2.2806 × 107+7.8125×104A+4.7447×108B+1.5284×108C-1.3857 × 103AB
- 1.6157 × 103AC-3.1633 × 104B2- 3.0159 × 104C2。
Analysis of variance table after optimization
Response surface curved surface can more intuitively reflect each factor and influence of the reciprocation of factor to response two-by-two.Radix Paeoniae Alba
In the contour map and response surface 3D map of ultrasonic extraction, concentration of alcohol influences maximum, followed by liquid material to Radix Paeoniae Alba extraction effect
Than influence of the ultrasonic time to Radix Paeoniae Alba extraction effect is minimum.Liquid-to-solid ratio and the reciprocation of concentration of alcohol are to Radix Paeoniae Alba extraction effect
It is affected, is secondly the reciprocation of liquid-to-solid ratio and ultrasonic time, the reciprocation of concentration of alcohol and ultrasonic time is least aobvious
It writes.
With the resulting Radix Paeoniae Alba ultrasonic extraction optimised process of Design-Expert8.0.6 software optimization are as follows: liquid-to-solid ratio
53.38mLg-1, concentration of alcohol 72.04%, ultrasonic time 20.06min, with this condition share peak total peak area prediction
Value is 2.1608 × 108。
2.7 verification tests are the reliability of auth response face method acquired results, are tested the process conditions of model optimization
Card.In view of the feasibility and convenience of experiment, technological parameter: solid-liquid ratio 53mLg- is selected1, concentration of alcohol 72%, ultrasound
Time 20min carries out experiment 3 times, illustrates equation and the fitting of actual experimental situation preferably, the process of optimization, feasible.
Compare respectively the mentioning by contained content assaying method and Optimized Extraction Process of Radix Paeoniae Alba in " Chinese Pharmacopoeia " (version in 2010)
Take effect.By CP method (liquid-to-solid ratio 500mLg-1, concentration of alcohol 50%, ultrasonic time 30min) prepare test solution 3
Part, sample detection records chromatogram, is compared with confirmatory experiment result.
As a result, it has been found that: it is high compared with CP method by 10.84% that response phase method optimizes the resulting shared peak total peak area of technique;If with Chinese herbaceous peony
The peak area of medicine glycosides is evaluation index, the resulting Paeoniflorin peak area of response surface optimization technique low compared with CP method 1.30%, without aobvious
Write difference, and liquid material is bigger in CP method, causes each ingredient response in extracting solution relatively low, in chromatogram peak number compared with
It is few.Therefore, from the point of view of Radix Paeoniae Alba quality thoroughly evaluating, response phase method optimizes resulting Radix Paeoniae Alba ultrasonic extraction process and mentions compared with pharmacopeia
Follow the example of more advantage.
Verification test
Since response phase method is to obtain corresponding point on the basis of experiment of single factor, and it is complete from these points to obtain one
Whole, continuous face, then optimal value is obtained in this face.Therefore, in response surface whole design, variable parameter in experiment of single factor
Selection seem especially crucial.The lower listed method of version " Chinese Pharmacopoeia " Radix Paeoniae Alba in 2010 is only used for the content detection of Paeoniflorin,
But reference value with higher, therefore 3 determined extraction time, concentration of alcohol, liquid-to-solid ratio techniques in this research experiment of single factor
The range of variable covers the technological parameter in official method, and expands the selection of technological parameter on the basis of official method
Section, to obtain more preferably Radix Paeoniae Alba extraction process.The monoterpene glycosides compounds such as contained Paeoniflorin and some facile hydrolysis in Radix Paeoniae Alba
Tannins are more sensitive to temperature, and stability is poor at high temperature, the result of this and extracting method primary dcreening operation in this experiment
It is consistent.And to have many advantages, such as extraction efficiency high, easy to operate, energy saving for ultrasonic method, therefore can be used as preferably Radix Paeoniae Alba extracting method.
The present invention first passes through experiment of single factor and chooses suitable parameter level, and with the response surface of Three factors-levels point
Analysis method investigates the extraction time of Radix Paeoniae Alba ultrasonic extraction process, concentration of alcohol, liquid-to-solid ratio, obtains optimal extract process
For ultrasonic time 20.06min, concentration of alcohol 72.04%, liquid-to-solid ratio 53.38mLg- 1, and work is demonstrated by confirmatory experiment
The feasibility of skill, and at the process conditions, the extraction effect of Radix Paeoniae Alba chemical component more fully, sufficiently, can be used for Radix Paeoniae Alba matter
The overall merit of amount, and foundation is provided for the comprehensive utilization of Radix Paeoniae Alba, exploitation.
There is the experimental data for adjusting blood glucose to make to the present invention below with reference to dendrobium nobile in health-care flour of the invention further
Description.
It 1, is polysaccharide type and its function of blood sugar reduction in analysis dendrobium nobile.
Method:
Dendrobium candidum Thick many candies are separated using DEAE- cellulose anion exchange chromatography, Trimethylsilation method is surveyed
Determine the monosaccharide composition of separating polyose, the structure of infrared spectrum characterization separating polyose.Using model induced by alloxan diabetes mice mould
Influence of the type research separating polyose to model mice fasting blood sugar, serum insulin level and glycated serum protein content.
As a result:
Isolated 4 kinds of separating polyoses in dendrobium nobile, the monosaccharide group of content highest separating polyose DOP1 become arabinose, half
Lactose, glucose and mannose (molar ratio 3.5: 1.2: 1.5: 1.0).Results of IR and monosaccharide composition research phase
Symbol, while showing that 4 kinds of separating polyoses are sulfated polysaccharide.4 kinds of separating polyoses can significantly reduce diabetes after 21d is administered
The fasting blood sugar (P < 0.01) of model mice improves serum insulin level (P < 0.05~0.01) and reduces saccharification
Serum albumin content (P < 0.01), wherein being acted on DOP1 most strong.
Conclusion:
Dendrobium nobile separating polyose has significant hypoglycemic effect.
Specifically:
1,1 material
Dendrobium officinale powder (commercially available);Trifluoroacetic acid, anhydrous pyridine, D-Fructose, D- xylose, D- galactolipin, L- sandlwood
Sugar, L-arabinose (commercially available);Phenol, D-Glucose, D-MANNOSE (commercially available);Alloxan, LiClO4(commercially available);
Regisil reagent (Regis company);Melbine (commercially available);Glycated serum protein measures reagent, insulin assay kit
(commercially available);Pure water (purifying of Milli-pore system), other reagents are that analysis is pure.
1.2 animal
SPF grades of ICR mouse (male, 18~22g), credit number: SCXK (Shanghai).2012-0002, quality certification number:
2015000501747。
2 methods and result
The extraction of 2.1 dendrobium candidum Thick many candies (DOP)
Process flow: dendrobium officinale powder → degreasing decoloring element → vacuum drying → hot water extraction → supernatant concentration → alcohol precipitation
Shallow lake → freeze-drying → dendrobium candidum Thick many candies → de- albumen → DEAE- cellulose column separation → concentration → ultrafiltration → freeze-drying → separation
Polysaccharide.
Degreasing decoloring element: dendrobium officinale powder adds dehydrated alcohol by liquid-to-solid ratio 5: 1, refluxing extraction 3 times, each 1h, filters
Filtrate is abandoned, 75 DEG C of filter cake vacuum drying remove fat-soluble pigment and small molecular weight impurity in raw material powder.
Dendrobium candidum Thick many candies (DOP) extract and assay: dendrobe powder after weighing a certain amount of degreasing decoloring element in
In 50mL centrifuge tube, by liquid-to-solid ratio 30: 1 add pure water, in thermostat water bath at 80 DEG C extract 2h after centrifuge the extract
(4000r/min, 15min),
Gained precipitating continues to extract 3 times and combined extract, and rotation is concentrated by evaporation to original volume half at 75 DEG C, adds 5
The dehydrated alcohol precipitating of amount, 4 DEG C of placement 12h, centrifugation (4000r/min, 15min) are lyophilized afterwards again, and Sevag method takes off albumen and obtains iron
Skin dendrobium nobile Thick many candies (DOP).Polyoses content after taking off albumen is measured using phend-sulphuric acid, by Dendrobium officinale polysaccharide yield=iron
Skin dendrobium nobile Thick many candies quality/dendrobium officinale powder quality × 100%, calculating yield is 18.56%.
2.2 dendrobium candidum Thick many candies (DOP's) isolates and purifies:
The separation of DEAE- cellulose column: -52 column of DEAE- cellulose (Whatman company) of 25mm × 500mm is utilized
Separate Thick many candies.It weighs 0.1g Thick many candies to be dissolved in 10mL pure water, utilizes the NaCl solution of 0,0.1,0.2,0.3 and 0.5mol/L
With the flow rate gradient of 1.0mL/min, test tube collects eluent, every pipe 10mL, and each gradient collects 10 pipes, phenolsulfuric acid
Method colour developing, monitors eluent absorbance value at 490nm, draws elution curve.According to elution curve set separating polyose component,
Using the concentration of Labscale ultrafiltration instrument, desalination, freeze-drying is centrifuged after alcohol precipitation.DOP obtains 4 components through above-mentioned 5 kinds of eluents,
It is successively denoted as DOP1, DOP2, DOP3 and DOP4, component is less after the N aCl solution elution of 0.5mol/L is difficult to collect.According to iron
Area ratio under skin dendrobium polysaccharide yield (18.56%) and 4 separating polyose component elution curves (17.2: 3.5: 2.1:
1.0), calculate each separating polyose yield is followed successively by 13.41%, 2.743%, 1.64% and 0.7 8%.
The monosaccharide composition analysis separating polyose of 2.3 dendrobium candidum separating polyoses hydrolyzes and balance isomerization: polysaccharide 5mg is taken,
4 mL of trifluoroacetic acid of 2mol/L is added, seals, is transferred in distilling flask the evaporated under reduced pressure at 60 DEG C after hydrolyzing 4h at 120 DEG C
(oil pump drains moisture).1mL pyridinium dissolution residue is added, 0.5mL is taken to be placed in scale test tube, 0.2%LiClO4 pyrrole is added
Pyridine solution 0.5mL, makes LiClO4 ultimate density 0.1%, and sealing of jumping a queue after mixing is placed isomerization for 24 hours and reached at 60 DEG C
To balance.
Separating polyose derivatization: the Regisil reagent of 1mL is added in above-mentioned polysaccharide hydrolysis solution, and vortex mixes, anti-at 60 DEG C
15min is answered to complete the Trimethylsilation of monosaccharide, precision pipettes supernatant pyrrole afterwards for centrifugation (50 00r/min, 10min)
Pyridine is dissolved in volumetric flask surely, is drawn 0.5mL and is carried out gas chromatographic analysis.
Monosaccharide standard derivatization: each monosaccharide standard (including glucose, mannose, galactolipin, arabinose, sandlwood
Sugar, xylose and fructose) derivatization method is same as above.
GC conditions: Shimadzu GC-2010 gas chromatograph;Chromatographic column: Shimadzu Inert Cap5 capillary chromatographic column
(30m×250μm×0.25μm);Temperature program: 18 0 DEG C of reservation 10min are warming up to 240 DEG C with the speed of 5 DEG C/min, then with
The speed of 20 DEG C/min is warming up to 300 DEG C and keeps 10min;Detector: hydrogen ion flame detector (FID);Injector temperature
260℃;1 μ L of sampling volume;300 DEG C of temperature of detection.
After mixing monosaccharide standard, dendrobium candidum Thick many candies (DOP), each separating polyose component Trimethylsilation
Gas chromatogram is Arabic it is found that monosaccharide constitutes and is at maximum up to 31.5% with glucose content in dendrobium candidum Thick many candies (DOP)
Sugar, xylose, galactolipin, rhamnose and mannose content are respectively 16.5%, 15%, 13.5%, 12.2% and 11.3%.4 kinds
Separating polyose component contains glucose, and wherein the highest separating polyose component DOP1 of content contains arabinose, galactolipin, Portugal
Grape sugar and mannose, monosaccharide constitutive molar ratio are 3.5: 1.2: 1.5: 1.0.In the less DOP3 and DOP4 monosaccharide composition of content
There are micro fructose.
2.4 dendrobium candidum separating polyose components each separating polyose sample of IR spectrum scanning (DOP1, DOP2, DOP3 and
DOP4) with dry KBr powder mixed grinding tabletting, infrared spectrometer scanning wavelength range is 4500~500cm- 1.4 groups
The Fourier transform infrared spectroscopy map analysis divided is it is found that 3400cm- 1Occurring biggish absorption peak at left and right is hydroxyl in polysaccharide molecule
Base group stretching vibration peak;2900cm- 1Neighbouring stronger absorption peak is-CH in polysaccharide molecule2C-H stretching vibration peak;
1730cm- 1Neighbouring absorption peak is-COOH group C=O stretching vibration peak;
1640cm- 1Neighbouring absorption peak is C=O stretching vibration peak in-COOR;
1380cm- 1Neighbouring absorption peak is C-O stretching vibration peak in-COOR;
1250cm- 1Neighbouring absorption peak is RSO2S=O stretching vibration peak in R;
1000~1200cm- 1Neighbouring absorption peak is pyranose ring C-O-C stretching vibration peak;
810cm- 1Neighbouring absorption peak is C-H stretching vibration peak in D- mannopyrane glucosides.Infrared analysis result and monosaccharide
The result of component is consistent.
The analysis of 2.5 Dendrobium officinale polysaccharide hypoglycemic effects:
Mouse modeling, grouping and administration take 18~22g of weight male 100 small, and adaptive feeding 3d selects 10 at random
It is only used as Normal group, alloxan physiology is injected intraperitoneally under 200m g/kg dosage for remaining mouse fasting 12h, free water
Saline solution (Normal group injects isometric physiological saline), establishes diabetes animal model.Fasting 12h, it is quiet in 72h rear molding
Arteries and veins blood sampling measurement fasting blood sugar, blood glucose value >=13mmol/L and it is continuous occur " three-many-one-little " symptom (more drinks, more foods, diuresis,
Weight mitigate), as modeling success mouse.
Proportionately mould animal body quality and blood glucose level randomly choose 60 and are divided into 6 groups in successful 75 mouse of modeling
(n=10), respectively model group, positive controls, DOP1 (40mg/k g) group, DOP2 (40mg/kg) group, DOP3 (40mg/
Kg) group and DOP4 (40mg/kg) group.It is administered by following scheme: control group and pure water 20mL/kg daily after model group modeling 7d
Stomach-filling;Positive controls give 200mg/kg melbine, and polysaccharide group presses the daily gastric infusion of various dose 1 time, continuous 21d,
Fasting 12h after administration.
Fasting 12h after administration in influence of the Dendrobium officinale polysaccharide to model mice fasting blood glucose level the 7th, 14 and 21 day, tail
Venous blood sampling measures fasting blood-glucose.Model group mouse fasting blood glucose level is significantly higher than concurrent control group mouse (P < 0.01), together
When in 21d mouse behavior expression meet model needs, diabetes animal model is reliable and stable;Positive control melbine group is given
After medicine 21d,
Mouse fasting blood-glucose is decreased significantly (P < 0.01) compared with model group, and blood glucose rate of descent is up to for each group
73.1%;Start to show different degrees of hypoglycemic effect after each polysaccharide group administration 7d, to being administered after 21d and same period model group
Comparing has significant difference (P < 0.01), and wherein up to 62.6% in polysaccharide group, secondly 1 group of blood glucose rate of descent of DOP is
For DOP2 group, reach 5 5.0%.
The 21st day measurement fasting blood of influence of the Dendrobium officinale polysaccharide to model mice insulin and glycated serum protein level
After sugar, mouse plucks eyeball and takes blood, and taken blood 3000r/min at 4 DEG C is centrifuged 1 0min, separates serum, say according to kit
Bright book measures serum insulin (INS) and glycated serum protein (GSP) content.The results show that polysaccharide group is aobvious compared with model group
Work improves diabetic mice insulin level in serum (P < 0.01), and wherein the effect of DOP1 group is most strong;After 21d is administered,
Positive controls and polysaccharide group significantly reduce glycated serum protein (GSP) level (P < in diabetic mice serum
0.01), most strong with positive controls effect, it is secondly DOP1 group.It follows that 4 kinds of dendrobium polysaccharides have drop at this dose
The effect of low diabetes model mouse blood sugar level, serum insulin and the horizontal variation tendency of glycated serum protein with it is aforementioned
Model mice fasting blood glucose level variation tendency is consistent.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Made any modifications, equivalent replacements, and improvements etc., should all be included in the protection scope of the present invention within mind and principle.
Claims (10)
1. a kind of health-care flour, which is characterized in that the health-care flour is according to mass fraction by 1 part -10 parts of pueraria lobata, 1 part of Radix Paeoniae Alba
~5 parts, 1 part~5 parts of dendrobium nobile, 1 part~2 parts of purslane, 1 part~2 parts of lotus leaf and 10 parts~20 parts of flour compositions.
2. a kind of preparation method of health-care flour as described in claim 1, which is characterized in that the preparation side of the health-care flour
Method, comprising the following steps:
Step 1: selected Chinese herb pueraria lobata, Radix Paeoniae Alba, dendrobium nobile, purslane, lotus leaf, cleaning, drying, disinfection are spare;
Step 2: Chinese medicine material is crushed, and is sieved for subsequent use;
Step 3 weighs 1 part -10 parts of pueraria lobata, 1 part~5 parts of Radix Paeoniae Alba, 1 part~5 parts of dendrobium nobile, 1 part~2 parts, 1 part of lotus leaf of purslane
~2 parts are mixed with 10 parts~20 parts of flour, are stirred evenly, and mixture is made;
Mixture is carried out separating twice by step 4, and sterilization, packaging obtains health-care flour.
3. the preparation method of health-care flour as claimed in claim 2, which is characterized in that in the step 2, Chinese herb
Crushing after granularity be less than the granularity equal to flour.
4. a kind of wheaten food of the preparation of the health-care flour as described in claim 1, which is characterized in that the health-care flour preparation
Wheaten food includes health-care powder steamed bun, health care flour noodle, the quick-frozen food with filling of health-care powder, health-care powder bread, health-care powder cake.
5. the extracting method of Radix Paeoniae Alba in a kind of health-care flour as described in claim 1, which is characterized in that the extraction side of the Radix Paeoniae Alba
Method includes: to choose suitable parameter level by experiment of single factor, and use the Responds Surface Methodology dialogue of Three factors-levels
The extraction time of Chinese herbaceous peony ultrasonic extraction process, concentration of alcohol, liquid-to-solid ratio are analyzed, when acquisition optimal extract process is ultrasound
Between 20.06min, concentration of alcohol 72.04%, liquid-to-solid ratio 53.38mLg- 1。
6. the extracting method of Radix Paeoniae Alba as claimed in claim 5, which is characterized in that the extracting method of the Radix Paeoniae Alba specifically includes:
It takes radix paeoniae alba decoction pieces to crush, crosses 50 meshes, precision is weighed in right amount, set in boiling flask, and the appropriate amount of ethanol of respective concentration is added, and is claimed
Fixed, 40kHz, 150W ultrasonic extraction is taken out and is stood to room temperature, and weighed quality of supplying is to get Radix Paeoniae Alba.
7. the extracting method of Radix Paeoniae Alba as claimed in claim 5, which is characterized in that in Radix Paeoniae Alba ultrasonic extraction, in single factor experiment
On the basis of, determine the level value of 3 liquid-to-solid ratio, concentration of alcohol and ultrasonic time factors, it is soft with Design-Expert8.0.6
Part carries out the design of Box-Behnken response surface and data carry out variance analysis and quadratic polynomial regression fit, regression model P are
0.0032, model is extremely significant;Losing quasi- item P is 0.2360, not significantly;The coefficient of determination is 0.9677, and the models fitting degree is good;
Factor A, B, B2, C2To significantly affect factor, illustrate to be affected to Radix Paeoniae Alba extraction effect;Model is optimized manually, in original
On the basis of having fit equation, not significant item BC and A is removed2Afterwards, optimize resulting actual value equation:
R=2.2806 × 107+7.8125×104A+4.7447×108B+1.5284×108C-1.3857 × 103AB-
1.6157×103AC-3.1633 × 104B2- 3.0159 × 104C2。
8. the extracting method of Radix Paeoniae Alba as claimed in claim 5, which is characterized in that with the response surface analysis of Three factors-levels
Before method analyzes the extraction time of Radix Paeoniae Alba ultrasonic extraction process, concentration of alcohol, liquid-to-solid ratio, need to carry out:
Reference substance solution preparation
Weigh gallic acid, catechin, albiflorin, Paeoniflorin, benzoic acid, 1,2,3,4,6-O- five galloyl grapes
Sugar, benzoylpaeoniflorin and Paeonol reference substance are appropriate, add methanol that every 1mL is made and contain 15.07 μ g of gallic acid, catechin respectively
5.49 μ g, 11.79 μ g of albiflorin, 35.15 μ g of Paeoniflorin, 7.87 μ g of benzoic acid, 1,2,3,4,6-O- five galloyl
7.84 μ g of glucose, 3.92 μ g of benzoylpaeoniflorin, the mixed reference substance solution of 7.94 μ g of Paeonol shake up, 4 DEG C of storages, standby
With;
The UPLC analysis condition of Radix Paeoniae Alba
ACQUITYUPLCHSST3 chromatographic column 2.1mm × 100mm, 1.8 μm;- 0.05% phosphate aqueous solution of mobile phase acetonitrile (A)
(B), gradient: 0~0.5min, 7%~14%A;0.5~3min, 14%A;3~5.5min, 14%~18%A;5.5~
6min, 18%~20%A;6~9min, 20%~22%A;9~9.5min, 22%~40%A;9.5~11min, 40%~
50%A;11~11.5min, 50%~100%A;11.5~12min, 100%A;12~12.5min, 100%~7%A;
12.5~14min, 7%A.Detection wavelength 230nm;30 DEG C of column temperature;Flow velocity 0.4mLmin- 1;2 μ L of sample volume;
The preliminary screening of Radix Paeoniae Alba ultrasonic method extracting method:
0.5g10 parts of radix paeoniae alba decoction pieces powder are weighed, is placed in boiling flask, it is each that 50% ethyl alcohol 50mL, weighed quality, wherein 5 is added
Part sample difference heating and refluxing extraction 0.5,1,1.5,2,2.5h, another 5 parts of samples difference ultrasonic extraction 10,30,50,70,
90min;Standing is extracted to room temperature, weighed to supply quality, 0.22 μm of filtering with microporous membrane takes subsequent filtrate;It selects in chromatogram
11 shared peaks of S/N > 20 are as evaluation index, and the unit crude drug peak area handled with ultrasonic 30min calculates for 100%
The shared peak peak area recovery rate of different disposal sample, is compared;Different Extraction Method is to 2,7, No. 8 peak peak area recovery rates
Be affected, on remaining share peak peak area influence it is not significant;It is tentatively pushed away by retention time corresponding with reference substance map
Survey: No. 2 peaks are gallic acid peak, and No. 7 peaks are benzoic acid peak, and No. 8 peaks are 1,2,3,4,6-O- five galloyl glucose peaks.
9. the method for dendrobium nobile effect of lowering blood sugar in health-care flour described in a kind of verifying claim 1, which is characterized in that the verifying
The method of dendrobium nobile effect of lowering blood sugar includes:
Dendrobium candidum Thick many candies, the measurement point of Trimethylsilation method are separated using DEAE- cellulose anion exchange chromatography
Monosaccharide composition from polysaccharide, the structure of infrared spectrum characterization separating polyose;Using model induced by alloxan diabetes mice model point
Analyse influence of the separating polyose to model mice fasting blood sugar, serum insulin level and glycated serum protein content.
10. the method for verifying dendrobium nobile effect of lowering blood sugar as claimed in claim 9, which is characterized in that the verifying dendrobium nobile is hypoglycemic
The method of effect specifically includes:
1) extraction of dendrobium nobile Thick many candies DOP;
2) dendrobium nobile Thick many candies DOP is isolated and purified;
3) monosaccharide composition analysis of dendrobium candidum separating polyose;
4) IR spectrum scanning of dendrobium candidum separating polyose component;
5) Dendrobium officinale polysaccharide hypoglycemic effect is analyzed: mouse modeling, grouping and administration take 18~22g of weight male small by 100
Only, adaptive feeding 3d selects 10 at random and is only used as Normal group, remaining mouse fasting 12h, free water, 200mg/kg
Alloxan normal saline solution is injected intraperitoneally under dosage, establishes diabetes animal model;Fasting 12h, tail vein is adopted after 72h
Hematometry fasting blood sugar, blood glucose value >=13mmol/L and continuous appearance " three-many-one-little " symptom, modeling success mouse;
Proportionately mould animal body quality and blood glucose level randomly choose 60 and are divided into 6 groups in successful 75 mouse of modeling, point
It Wei not model group, positive controls, DOP140mg/kg group, DOP240mg/kg group, DOP340mg/kg group and DOP440mg/kg
Group;
It is administered by following scheme: control group and pure water 20mL/kg stomach-filling daily after model group modeling 7d;Positive controls are given
200mg/kg melbine, polysaccharide group press the daily gastric infusion of various dose 1 time, continuous 21d, fasting 12h after administration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811363681.2A CN109527351A (en) | 2018-11-16 | 2018-11-16 | A kind of health-care flour and preparation method thereof, wheaten food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811363681.2A CN109527351A (en) | 2018-11-16 | 2018-11-16 | A kind of health-care flour and preparation method thereof, wheaten food |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109527351A true CN109527351A (en) | 2019-03-29 |
Family
ID=65847869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811363681.2A Pending CN109527351A (en) | 2018-11-16 | 2018-11-16 | A kind of health-care flour and preparation method thereof, wheaten food |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109527351A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111869869A (en) * | 2020-07-28 | 2020-11-03 | 菏泽瑞璞牡丹产业科技发展有限公司 | Peony and peony health flour and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101653255A (en) * | 2009-08-27 | 2010-02-24 | 杨波 | Flour suitable for patients with diabetes mellitus |
CN103478592A (en) * | 2013-09-28 | 2014-01-01 | 武汉凌科达科技有限公司 | Health care noodles containing Chinese herbal medicine and production process of health care noodles |
CN104304984A (en) * | 2014-10-27 | 2015-01-28 | 四川省朝花夕拾科技有限公司 | Health noodles containing Chinese herbal medicine recipe and production process of health noodles |
CN104544140A (en) * | 2015-01-12 | 2015-04-29 | 陈航 | Five-cereal health food and preparation method thereof |
CN106173605A (en) * | 2015-04-29 | 2016-12-07 | 无限极(中国)有限公司 | A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Herba Dendrobii |
CN106418140A (en) * | 2016-08-23 | 2017-02-22 | 济南东旭食品有限公司 | Tartary buckwheat and lotus leaf healthy flour and product thereof |
CN106819833A (en) * | 2017-02-23 | 2017-06-13 | 湖北万星面业股份有限公司 | A kind of noodles of hypoglycemic Adjust-blood lipid and preparation method thereof |
CN107897667A (en) * | 2017-11-16 | 2018-04-13 | 徐州宏昌粮油购销有限责任公司 | A kind of health care composite flour and preparation method thereof |
-
2018
- 2018-11-16 CN CN201811363681.2A patent/CN109527351A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101653255A (en) * | 2009-08-27 | 2010-02-24 | 杨波 | Flour suitable for patients with diabetes mellitus |
CN103478592A (en) * | 2013-09-28 | 2014-01-01 | 武汉凌科达科技有限公司 | Health care noodles containing Chinese herbal medicine and production process of health care noodles |
CN104304984A (en) * | 2014-10-27 | 2015-01-28 | 四川省朝花夕拾科技有限公司 | Health noodles containing Chinese herbal medicine recipe and production process of health noodles |
CN104544140A (en) * | 2015-01-12 | 2015-04-29 | 陈航 | Five-cereal health food and preparation method thereof |
CN106173605A (en) * | 2015-04-29 | 2016-12-07 | 无限极(中国)有限公司 | A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Herba Dendrobii |
CN106418140A (en) * | 2016-08-23 | 2017-02-22 | 济南东旭食品有限公司 | Tartary buckwheat and lotus leaf healthy flour and product thereof |
CN106819833A (en) * | 2017-02-23 | 2017-06-13 | 湖北万星面业股份有限公司 | A kind of noodles of hypoglycemic Adjust-blood lipid and preparation method thereof |
CN107897667A (en) * | 2017-11-16 | 2018-04-13 | 徐州宏昌粮油购销有限责任公司 | A kind of health care composite flour and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
汤志远等: "铁皮石斛多糖降血糖作用研究", 《南京中医药大学学报》 * |
金林: "响应面法优化白芍提取工艺的研究", 《中国中药杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111869869A (en) * | 2020-07-28 | 2020-11-03 | 菏泽瑞璞牡丹产业科技发展有限公司 | Peony and peony health flour and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
CN104435775A (en) | Chinese medicinal health-care spirit and preparation method thereof | |
CN102258708A (en) | Health-preserving wine and preparation method thereof | |
CN106509261A (en) | Sugar-free herbal tea plant composition, and method for preparing drink and granule from composition | |
CN104398986A (en) | Tranquilization and brain tonifying epimedium herb oral liquid and preparation method thereof | |
CN112409504B (en) | Preparation method and application of Sipunculus nudus polysaccharide | |
CN112336815A (en) | Anti-aging composition for strengthening body, preventing cancer and conditioning hypertension, hyperglycemia and hyperlipidemia and application thereof | |
CN103749818B (en) | A kind of sealwort hypoglycemic health protection tea and preparation method thereof | |
CN104857154A (en) | Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor | |
CN103637179A (en) | Food composition with functions of lowering blood sugar and blood fat and improving fatty liver | |
CN103749819B (en) | Fructus Corni health protection tea of a kind of hypoglycemic and preparation method thereof | |
CN103432192B (en) | A kind of compositions with antiobesity action | |
CN109527351A (en) | A kind of health-care flour and preparation method thereof, wheaten food | |
CN101474346B (en) | Longstamen onion bulb extract as well as preparation method and application thereof | |
CN101564169A (en) | Medlar nutriment, and preparation and application thereof | |
CN103041070A (en) | Lipid-lowering and pressure-releasing folium ginkgo health-care product and preparation method thereof | |
CN105533749B (en) | It is a kind of containing Herba Epimedii, the health food of Schisandra chinensis and its preparation method and application | |
CN106928376A (en) | The separation method of skunk bush polysaccharide and its application | |
CN107468952A (en) | A kind of preparation method of the integration of drinking and medicinal herbs composition with auxiliary hyperglycemic function | |
CN114145374A (en) | Astragalus membranaceus and corn stigma composite tea and preparation method and application thereof | |
CN104491474B (en) | A kind of Chinese medicine composition of auxiliary hyperglycemic and preparation method thereof | |
CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
CN103082298B (en) | Health-care food for reducing blood glucose in assisted mode and preparation method thereof | |
CN105963567B (en) | The drug and preparation method for treating diabetes | |
CN101744996B (en) | Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190329 |